【正文】 n the treatment of hairy cell leukemia. Best Pract Res Clin Haematol. 2003 Mar。16(1):919.18. Matutes E, Wotherspoon A, Catovsky D.：The variant form of hairy cell leukemia. Best Pract Res Clin Haematol. 2003 Mar。16(1):4156.19. Mey U, Strehl J, Gorschluter M, Ziske C, Glasmacher A, Pralle H, SchmidtWolf I.：Advances in the treatment of hairy cell leukemia. Lancet Oncol. 2003 Feb。4(2):8694.20. Kreitman RJ.：Rebinant toxins for the treatment of cancer. Curr Opin Mol Ther. 2003 Feb。5(1):4451.21. Zuzel M，Cawley JC.：The biology of hairy cells. Best Pract Res Cline Haematol. 2003 Mar。16(1):113.22. Bethel KJ,Sharpe RW.：Pathology of hairycell leukaemia. Best Pract Res Clin Haematol. 2003 Mar。16(1):1531.23. Bosly A, Keating MJ, Stasi R, Bradstock K.：Rituximab in Bcell disorders other than nonHodgkin39。s lymphoma. Anticancer Drugs. 2002 Nov。13 Suppl 2:S2533.24. Allsup DJ, Cawley JC.：The diagnosis and treatment of hairy cell leukemia. Blood Rev. 2002 Dec。16(4):25562.25. Tallman MS.：Monoclonal antibody therapies in leukemias. Semin Hematol. 2002 Oct。39(4 Suppl 3):129.26. Todd SA, Morris TC, Alexander HD.：Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2deoxycoformycin. Leuk Lymphoma. 2002 Jun。43(6):13434.27. Gine E, Bosch F, Villamor N, Rozman M, Colomer D, LopezGuillermo A, Campo E, Montserrat E.：Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association? Leukemia. 2002 Aug。16(8):14549.難治性幼淋細胞白血病 AM, Keating al：Richter syndrome: biology, incidence, and therapeutic strategies. Cancer. 2005 Jan 15；103(2):21628. C.：Alemtuzumab in peripheral Tcell malignancies. Cancer Biother Radiopharm. 2004 Aug；19(4):3918.3. Lee SS, Robinson MR, Morris JC, Mirtsching BC, Shen D, Chan CC. et al：Conjunctival involvement with Tcell prolymphocytic leukemia: report of a case and review of the literature. Surv Ophthalmol. 2004 SepOct；49(5):52536.4. Hsi ED, Frater JL. et al：Advances in the diagnosis and classification of chronic lymphoproliferative disorders. Cancer Treat Res. 2004；121:14565.5. Robak T.：Monoclonal antibodies in the treatment of chronic lymphoid Lymphoma. 2004 Feb；45(2):20519.6. Ruchlemer R, ParryJones N, BritoBabapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D. et al：B prolymphocytic leukemia with t(11；14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol. 2004 May；125(3):3306. SA. ：Use of fludarabine in the treatment of mantle cell lymphoma, Waldenstrom39。s macroglobulinemia and other unmon B and Tcell lymphoid J. 2004；5 Suppl 1:S5061.8. Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M, Kipps TJ. et al：Biology and treatment of chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program). 2003；15375.9. Frampton JE, Wagstaff AJ. et al：Alemtuzumab. Drugs. 2003；63(12):122943； discussion 12456.10. Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ. et al ：Mature Bcell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphomatype chromosomal translocations involving cmyc. Arch Pathol Lab Med. 2003 Mar；127(3):3059.11. Cao TM, Coutre SE. et al：Tcell prolymphocytic leukemia: update and focus on alemtuzumab （Campath1H）. Hematology. 2003 Feb；8(1):16.12. Tamayose K, Sato N, Ando J, Sugimoto K, Oshimi K. et al：CD3negative, CD20positive Tcell prolymphocytic leukemia: case report and review of the literature. Am J Hematol. 2002 Dec；71(4):3315.13. Tallman MS.：Monoclonal antibody therapies in leukemias. Semin Hematol. 2002 Oct；39(4 Suppl 3):129.14. Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM. et al：ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma. 2002 Aug；43(8):156371.15. Dearden CE, Matutes E, Catovsky D. et al：Alemtuzumab in Tcell malignancies. Med Oncol. 2002；19 Suppl:S2732.16. Dumont FJ.：CAMPATH (alemtuzumab) for the treatment of chronic lymphocytic leukemia and beyond. Expert Rev Anticancer Ther. 2002 Feb；2(1):2335.17. Westin EH, Longo al：Tsmall cell disorders. Curr Treat Options Oncol. 2001 Jun；2(3):22535.18. Keating MJ, O39。Brien S, Albitar M. et al：Emerging information on the use of rituximab in chronic lymphocytic leukemia. Semin Oncol. 2002 Feb；29(1 Suppl 2):704.19. Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, Siakantaris MP. et al：Campath1H (antiCD52) monoclonal antibody therapy in lymphoproliferative disorders. Med Oncol. 2001；18(2):99107.20. Ferrajoli A, O39。Brien S, Keating MJ. et al：Alemtuzumab: a novel monoclonal antibody. Expert Opin Biol Ther. 2001 Nov；1(6):105965.21. Boultwood J.：Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol. 2001 Jul；54(7):5126.中英文日報導(dǎo)航站